Literature DB >> 16162343

In vitro assembly of mosaic hepatitis B virus capsid-like particles (CLPs): rescue into CLPs of assembly-deficient core protein fusions and FRET-suited CLPs.

Maren Vogel1, Manuel Diez, Jochen Eisfeld, Michael Nassal.   

Abstract

Hepatitis B virus core protein self-assembles into icosahedral, highly immunogenic capsid-like particles (CLPs) that can serve as molecular platforms for heterologous proteins. Insertion into the centrally located c/e1 epitope leads to surface display, fusion to the C terminus to internal disposition of the foreign domains. However, symmetry-defined space restrictions on the surface and particularly inside the CLPs limit the size of usable heterologous fusion partners. Further, CLPs carrying differing foreign domains are desirable for applications such as multivalent vaccines, and for structure probing by distance sensitive interactions like fluorescence resonance energy transfer (FRET). Here, we report an in vitro co-assembly system for such mosaic-CLPs allowing successful CLP formation with a per se assembly-deficient fusion protein, and of CLPs from two different fluoroprotein-carrying fusions that exert FRET in an assembly-status dependent way.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16162343     DOI: 10.1016/j.febslet.2005.08.044

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  19 in total

1.  Global structural changes in hepatitis B virus capsids induced by the assembly effector HAP1.

Authors:  Christina R Bourne; M G Finn; Adam Zlotnick
Journal:  J Virol       Date:  2006-08-30       Impact factor: 5.103

2.  In vitro screening for molecules that affect virus capsid assembly (and other protein association reactions).

Authors:  Adam Zlotnick; Angela Lee; Christina R Bourne; Jennifer M Johnson; Paul L Domanico; Stephen J Stray
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

3.  Internal core protein cleavage leaves the hepatitis B virus capsid intact and enhances its capacity for surface display of heterologous whole chain proteins.

Authors:  Andreas Walker; Claudia Skamel; Jolanta Vorreiter; Michael Nassal
Journal:  J Biol Chem       Date:  2008-09-30       Impact factor: 5.157

Review 4.  Going Viral with Fluorescent Proteins.

Authors:  Lindsey M Costantini; Erik L Snapp
Journal:  J Virol       Date:  2015-07-22       Impact factor: 5.103

5.  Expression, purification, crystallization and preliminary X-ray crystallographic studies of hepatitis B virus core fusion protein corresponding to octahedral particles.

Authors:  Masaki Kikuchi; Shinichiro Iwabuchi; Tatsuhiko Kikkou; Keiichi Noguchi; Masafumi Odaka; Masafumi Yohda; Masaaki Kawata; Chikara Sato; Osamu Matsumoto
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2013-01-31

6.  A structural model for duck hepatitis B virus core protein derived by extensive mutagenesis.

Authors:  Michael Nassal; Immanuel Leifer; Ida Wingert; Kai Dallmeier; Simone Prinz; Jolanta Vorreiter
Journal:  J Virol       Date:  2007-09-19       Impact factor: 5.103

7.  Protein Nanoparticles as Multifunctional Biocatalysts and Health Assessment Sensors.

Authors:  Maryam Raeeszadeh-Sarmazdeh; Emily Hartzell; J Vincent Price; Wilfred Chen
Journal:  Curr Opin Chem Eng       Date:  2016-09-04       Impact factor: 5.163

8.  A mutant hepatitis B virus core protein mimics inhibitors of icosahedral capsid self-assembly.

Authors:  Christina R Bourne; Sarah P Katen; Matthew R Fulz; Charles Packianathan; Adam Zlotnick
Journal:  Biochemistry       Date:  2009-03-03       Impact factor: 3.162

9.  Tandem fusion of hepatitis B core antigen allows assembly of virus-like particles in bacteria and plants with enhanced capacity to accommodate foreign proteins.

Authors:  Hadrien Peyret; Annick Gehin; Eva C Thuenemann; Donatienne Blond; Aadil El Turabi; Lucy Beales; Dean Clarke; Robert J C Gilbert; Elizabeth E Fry; David I Stuart; Kris Holmes; Nicola J Stonehouse; Mike Whelan; William Rosenberg; George P Lomonossoff; David J Rowlands
Journal:  PLoS One       Date:  2015-04-01       Impact factor: 3.240

10.  Vaccine delivery system for tuberculosis based on nano-sized hepatitis B virus core protein particles.

Authors:  Dhananjayan Dhanasooraj; R Ajay Kumar; Sathish Mundayoor
Journal:  Int J Nanomedicine       Date:  2013-02-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.